Control | HTN | |
---|---|---|
(n = 40) | (n = 60) | |
Age, years | 42 ± 13 | 55 ± 12* |
Age range, years | 20-69 | 26-76 |
Males,% | 52 | 52 |
SBP, mmHg | 118 ± 14 | 144 ± 16* |
DBP, mmHg | 74 ± 11 | 88 ± 13* |
HR, beats/minute | 71 ± 13 | 68 ± 12 |
Duration of HTN, years | 0 | 17 ± 10 |
Number of anti-HTN medications | 0 | 4 ± 1 |
Beta blocker (%) | 0 | 75 |
ACE-I (%) | 0 | 62 |
ARB (%) | 0 | 53 |
CCB (%) | 0 | 68 |
Diuretic (%) | 0 | 92 |
Other (%) | 0 | 37 |
BUN, mg/dl | 11.73 ± 3.69 | 13.04 ± 6.19 |
Creatinine, mg/dl | 0.94 ± 0.19 | 1.05 ± 0.26* |